PL372809A1 - Podstawione pochodne 1,3-difenyloprop-2-en-1-onu,sposób otrzymywania i zastosowanie podstawionych pochodnych 1,3-difenyloprop-2-enu-1-onu - Google Patents
Podstawione pochodne 1,3-difenyloprop-2-en-1-onu,sposób otrzymywania i zastosowanie podstawionych pochodnych 1,3-difenyloprop-2-enu-1-onuInfo
- Publication number
- PL372809A1 PL372809A1 PL03372809A PL37280903A PL372809A1 PL 372809 A1 PL372809 A1 PL 372809A1 PL 03372809 A PL03372809 A PL 03372809A PL 37280903 A PL37280903 A PL 37280903A PL 372809 A1 PL372809 A1 PL 372809A1
- Authority
- PL
- Poland
- Prior art keywords
- derivatives
- diphenylprop
- substituted
- preparation
- relates
- Prior art date
Links
- DQFBYFPFKXHELB-VAWYXSNFSA-N trans-chalcone Chemical class C=1C=CC=CC=1C(=O)\C=C\C1=CC=CC=C1 DQFBYFPFKXHELB-VAWYXSNFSA-N 0.000 title abstract 2
- 201000006474 Brain Ischemia Diseases 0.000 abstract 1
- 206010008120 Cerebral ischaemia Diseases 0.000 abstract 1
- 206010008118 cerebral infarction Diseases 0.000 abstract 1
- 239000008194 pharmaceutical composition Chemical class 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
- C07C323/51—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
- C07C323/52—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/22—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and doubly-bound oxygen atoms bound to the same carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C67/00—Preparation of carboxylic acid esters
- C07C67/30—Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C67/00—Preparation of carboxylic acid esters
- C07C67/30—Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group
- C07C67/333—Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group by isomerisation; by change of size of the carbon skeleton
- C07C67/343—Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
- C07C69/67—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of saturated acids
- C07C69/708—Ethers
- C07C69/712—Ethers the hydroxy group of the ester being etherified with a hydroxy compound having the hydroxy group bound to a carbon atom of a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
- C07C69/73—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids
- C07C69/738—Esters of keto-carboxylic acids or aldehydo-carboxylic acids
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyrane Compounds (AREA)
Abstract
Wynalazek dotyczy nowych podstawionych pochodnych 1,3-difenyloprop-2-en-1-onu, farmaceutycznych kompozycji zawierających te pochodne, ich zastosowań terapeutycznych, w szczególności do leczenia niedokrwienia mózgowego. Wynalazek dotyczy również sposobu otrzymywania tych pochodnych.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0208571A FR2841900B1 (fr) | 2002-07-08 | 2002-07-08 | Nouveaux derives de 1,3-diphenylprop-2-en-1-one substitues, preparation et utilisations |
Publications (2)
Publication Number | Publication Date |
---|---|
PL372809A1 true PL372809A1 (pl) | 2005-08-08 |
PL207362B1 PL207362B1 (pl) | 2010-12-31 |
Family
ID=29725283
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL372809A PL207362B1 (pl) | 2002-07-08 | 2003-07-08 | Podstawione pochodne 1,3-difenyloprop-2-en-1-onu, sposób otrzymywania tych związków , kompozycje farmaceutyczne zawierające te związki oraz zastosowanie tych związków |
Country Status (24)
Country | Link |
---|---|
US (3) | US7943661B2 (pl) |
EP (1) | EP1525177B1 (pl) |
JP (1) | JP4575771B2 (pl) |
KR (1) | KR100974577B1 (pl) |
CN (1) | CN100548960C (pl) |
AT (1) | ATE365703T1 (pl) |
AU (1) | AU2003264698B2 (pl) |
BR (1) | BRPI0312398B8 (pl) |
CA (1) | CA2490986C (pl) |
CY (1) | CY1108085T1 (pl) |
DE (1) | DE60314633T2 (pl) |
DK (1) | DK1525177T3 (pl) |
EA (1) | EA011090B1 (pl) |
ES (1) | ES2287528T3 (pl) |
FR (1) | FR2841900B1 (pl) |
IL (2) | IL165696A0 (pl) |
MX (1) | MXPA05000427A (pl) |
NO (1) | NO329700B1 (pl) |
NZ (1) | NZ538051A (pl) |
PL (1) | PL207362B1 (pl) |
PT (1) | PT1525177E (pl) |
SI (1) | SI1525177T1 (pl) |
WO (1) | WO2004005233A1 (pl) |
ZA (1) | ZA200501082B (pl) |
Families Citing this family (44)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2841900B1 (fr) | 2002-07-08 | 2007-03-02 | Genfit S A | Nouveaux derives de 1,3-diphenylprop-2-en-1-one substitues, preparation et utilisations |
FR2841784B1 (fr) * | 2002-07-08 | 2007-03-02 | Composition a base de derives de 1,3-diphenylprop-2en-1-one substitues, preparation et utilisations | |
EP1701938B1 (fr) * | 2004-01-08 | 2012-07-25 | Genfit | Composes derives de 1,3-diphenylprop-2-en-1-one, preparation et utilisations |
FR2902789A1 (fr) | 2006-06-21 | 2007-12-28 | Genfit Sa | Derives de 1,3-diphenylpropane substitues, preparations et utilisations |
US20100285126A1 (en) * | 2007-08-02 | 2010-11-11 | Rahul Dabre | Pharmaceutical compositions of fenofibrate |
CN102647982B (zh) * | 2009-11-26 | 2014-10-15 | 基恩菲特公司 | 使用1,3-二苯基丙-2-烯-1-酮衍生物治疗肝脏疾患 |
US9221751B2 (en) | 2009-11-26 | 2015-12-29 | Genfit | Use of 1,3-diphenylprop-2-en-1-one derivatives for treating liver disorders |
US10722575B2 (en) | 2009-11-26 | 2020-07-28 | Genfit | Use of 1,3-diphenylprop-2-en-1-one derivatives for treating liver disorders |
WO2011080276A1 (en) | 2009-12-29 | 2011-07-07 | Genfit | Pharmaceutical combinations comprising a dpp-4 inhibitor and a 1,3-diphenylprop-2-en-1-one derivative |
EP2571843B1 (en) | 2010-05-17 | 2017-12-27 | Genfit | Improved preparation of chalcone derivatives |
TWI415600B (zh) * | 2011-08-10 | 2013-11-21 | Univ Kaohsiung Medical | 用於治療動脈粥狀硬化的組合物及其製備方法 |
CA2858285C (en) | 2011-12-28 | 2021-06-08 | Genfit | 1,3-diphenylpropane derivatives, preparations and uses thereof |
CN102697757B (zh) * | 2012-05-18 | 2014-06-04 | 广州军区广州总医院 | 对羟基苄叉丙酮在制备预防和/或治疗脑病药物中的应用 |
CA2897258C (en) * | 2013-01-18 | 2021-02-02 | Genfit | Methods of treatment of fibrosis and cancers |
EP3416629A4 (en) * | 2016-02-16 | 2019-08-07 | CoNCERT Pharmaceuticals, Inc. | DEUTERATED GFT-505 |
EP4233910A3 (en) | 2016-03-31 | 2024-01-17 | Genfit | Methods of treatment of cholestatic diseases |
FR3056909B1 (fr) * | 2016-09-30 | 2019-04-19 | Nashpharm | Composition comprenant au moins un sel pharmaceutiquement acceptable d'elafibranor soluble en milieux aqueux presentant une absorption intestinale amelioree |
FR3056908B1 (fr) * | 2016-09-30 | 2019-04-19 | Nashpharm | Sel de metformine et d'elafibranor presentant une activite duale pour le traitement de l'obesite associee a la steato-hepatite non alcoolique (nash) et a l'hypertriglyceridemie |
CA3047098A1 (en) * | 2016-12-16 | 2018-06-21 | Jia Zhou | Inhibitors of bromodomain-containing protein 4 (brd4) |
WO2018133705A1 (zh) | 2017-01-22 | 2018-07-26 | 苏州科睿思制药有限公司 | Gft-505的晶型及其制备方法和用途 |
US20200054589A1 (en) | 2017-02-21 | 2020-02-20 | Genfit | Combination of a ppar agonist with a fxr agonist |
US11590108B2 (en) | 2017-02-24 | 2023-02-28 | Genfit | Pharmaceutical compositions for combination therapy |
KR20190136079A (ko) | 2017-04-18 | 2019-12-09 | 장피트 | 엘라피브라노르와 같은 ppar 작용제 및 아세틸-coa 카르복실라아제 (acc) 저해제를 포함하는 조합 |
CN108658908B (zh) | 2017-07-31 | 2019-05-10 | 广州必贝特医药技术有限公司 | 1,3-二取代烯酮类化合物及其应用 |
CN111183132A (zh) | 2017-08-04 | 2020-05-19 | 阿德万泰克咨询与技术股份有限公司 | Elafibranor的制备方法及新型合成中间体 |
US20190076500A1 (en) | 2017-09-13 | 2019-03-14 | Novartis Ag | Combinations comprising fxr agonists |
US20200283381A1 (en) | 2017-11-16 | 2020-09-10 | Teva Pharmaceuticals International Gmbh | Solid state forms of elafibranor |
CN111148742B (zh) | 2017-11-30 | 2021-11-16 | 四川科伦博泰生物医药股份有限公司 | 芳香族化合物及其药物组合物和用途 |
EP3514541A1 (de) * | 2018-01-17 | 2019-07-24 | Siemens Healthcare Diagnostics Products GmbH | Verfahren zur quantitativen bestimmung eines therapeutischen tnf-alpha inhibitors |
WO2019186410A1 (en) * | 2018-03-27 | 2019-10-03 | Lupin Limited | Solid forms of elafibranor and processes thereof |
TW202019870A (zh) | 2018-08-03 | 2020-06-01 | 法商Genfit公司 | 艾拉菲諾鹽 |
WO2020039297A1 (en) * | 2018-08-24 | 2020-02-27 | Mankind Pharma Ltd. | Novel compounds and their use in preparation of elafibranor and pharmaceutical acceptable salts thereof |
WO2020115628A1 (en) * | 2018-12-03 | 2020-06-11 | Mankind Pharma Ltd. | Solid forms of elafibranor and process of preparation thereof |
CN110156648A (zh) * | 2019-05-30 | 2019-08-23 | 河北科技大学 | 一种Elafibranor中间体的制备方法 |
CN114630660A (zh) | 2019-10-28 | 2022-06-14 | 基恩菲特公司 | 具有抗氧化特性的联合疗法 |
CN112824380A (zh) * | 2019-11-21 | 2021-05-21 | 杭州百诚医药科技股份有限公司 | α-氟代查耳酮类衍生物及其应用 |
CN111138264B (zh) * | 2019-11-29 | 2023-08-04 | 温州医科大学 | 一种丁香醛衍生物及其在制备抗妇科肿瘤药物中的应用 |
CN113121394B (zh) * | 2019-12-30 | 2022-11-08 | 中国药科大学 | 一种苯氧乙酸类衍生物的制备方法 |
AU2021219286A1 (en) * | 2020-02-10 | 2022-09-22 | Genfit | Polymorphs of elafibranor |
IL297436A (en) | 2020-05-18 | 2022-12-01 | Genfit | Alfibernor for the treatment of primary sclerosing cholangitis |
KR20230058104A (ko) | 2020-08-26 | 2023-05-02 | 장피트 | 원발 담즙성 담관염의 치료를 위한 조성물 및 방법 |
CN113230240B (zh) * | 2021-03-22 | 2022-12-27 | 广州医科大学 | 1,3-二苯基丙-2-烯-1-酮衍生物及其应用 |
CN114853686B (zh) | 2021-08-23 | 2023-06-20 | 中国药科大学 | 三氮唑酮类化合物及其医药用途 |
CN115894379A (zh) | 2022-01-20 | 2023-04-04 | 中国药科大学 | 海因类化合物及其医药用途 |
Family Cites Families (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3558612A (en) * | 1968-05-22 | 1971-01-26 | Dow Chemical Co | Substituted phenoxyacetic acids |
CH593224A5 (pl) * | 1973-10-30 | 1977-11-30 | Taisho Pharmaceutical Co Ltd | |
US3994955A (en) | 1975-01-20 | 1976-11-30 | G. D. Searle & Co. | Substituted phenoxydialkylacetic acids and esters |
JPS5278856A (en) | 1975-12-26 | 1977-07-02 | Taisho Pharmaceut Co Ltd | Preparation of chalcone ethers |
US4190671A (en) * | 1977-03-17 | 1980-02-26 | Biorex Laboratories Limited | Chalcone derivatives |
JPS5419947A (en) | 1977-07-16 | 1979-02-15 | Taisho Pharmaceut Co Ltd | Chalcone derivatives |
GB8426424D0 (en) * | 1984-10-19 | 1984-11-28 | Biorex Laboratories Ltd | Chalcone derivatives |
JPS6310720A (ja) | 1986-07-01 | 1988-01-18 | Nippon Kayaku Co Ltd | 5−リポキシゲナ−ゼ阻害剤および抗アレルギ−剤 |
JPH023670A (ja) | 1988-06-22 | 1990-01-09 | Nippon Oil & Fats Co Ltd | アルキルチオカルコン誘導体 |
AU634189B2 (en) * | 1988-11-25 | 1993-02-18 | Dainippon Ink And Chemicals Inc. | Therapeutic agent for renal disorders |
JPH0442229A (ja) * | 1990-06-08 | 1992-02-12 | Fujitsu Ltd | レジスト材料およびパターンの形成方法 |
JPH05255655A (ja) | 1992-03-12 | 1993-10-05 | Kanebo Ltd | 紫外線吸収剤 |
JPH06122623A (ja) | 1992-10-09 | 1994-05-06 | Minofuaagen Seiyaku Honpo:Goushi | 抗腫瘍剤 |
US5276058A (en) * | 1993-06-09 | 1994-01-04 | Nippon Hypox Laboratories Incorporated | 3,4-dihydroxychalcone derivatives |
DE4327365A1 (de) * | 1993-08-14 | 1995-02-16 | Boehringer Mannheim Gmbh | Verwendung von Phenolen und Phenolderivaten als Arzneimittel mit fibrinogensenkender Wirkung |
US5523302A (en) * | 1993-11-24 | 1996-06-04 | The Du Pont Merck Pharmaceutical Company | Aromatic compounds containing basic and acidic termini useful as fibrinogen receptor antagonists |
AU5474198A (en) | 1996-12-24 | 1998-07-17 | National Research Council Of Canada | Treatment of diseases or prevention of cellular damage caused by oxygen-containing free radicals |
EP0947511A1 (en) | 1998-03-30 | 1999-10-06 | F. Hoffmann-La Roche Ag | Derivatives of phenoxy acetic acid and of phenoxymethyl tetrazole having antitumor activity |
WO2000023073A1 (en) | 1998-10-20 | 2000-04-27 | Korea Institute Of Science And Technology | Bioflavonoids as plasma high density lipoprotein level increasing agent |
EP1254658B1 (en) * | 2000-01-27 | 2008-09-24 | Takara Bio Inc. | Remedies for the treatment of nerve diorders |
IL153565A0 (en) | 2000-06-20 | 2003-07-06 | Atherogenics Inc | 1,3-bis-(substituted-phenyl)-2-propen-1-ones and their use to treat vcam-1 mediated disorders |
EP1254759B1 (de) | 2001-05-03 | 2009-03-18 | Leister Process Technologies | Düse zum Schweissen von Kunststoffbahnen oder -folien |
FR2841900B1 (fr) | 2002-07-08 | 2007-03-02 | Genfit S A | Nouveaux derives de 1,3-diphenylprop-2-en-1-one substitues, preparation et utilisations |
FR2841784B1 (fr) * | 2002-07-08 | 2007-03-02 | Composition a base de derives de 1,3-diphenylprop-2en-1-one substitues, preparation et utilisations | |
FR2857361B1 (fr) * | 2003-07-08 | 2005-09-09 | Genfit S A | PREPARATION DE DERIVES DE 1,3-DIPHENYPROP-2-¼n-1-one |
EP1701938B1 (fr) * | 2004-01-08 | 2012-07-25 | Genfit | Composes derives de 1,3-diphenylprop-2-en-1-one, preparation et utilisations |
-
2002
- 2002-07-08 FR FR0208571A patent/FR2841900B1/fr not_active Expired - Fee Related
-
2003
- 2003-07-08 AT AT03762749T patent/ATE365703T1/de active
- 2003-07-08 EA EA200500169A patent/EA011090B1/ru not_active IP Right Cessation
- 2003-07-08 JP JP2004518890A patent/JP4575771B2/ja not_active Expired - Lifetime
- 2003-07-08 KR KR1020057000349A patent/KR100974577B1/ko active IP Right Grant
- 2003-07-08 WO PCT/FR2003/002127 patent/WO2004005233A1/fr active IP Right Grant
- 2003-07-08 PL PL372809A patent/PL207362B1/pl unknown
- 2003-07-08 NZ NZ538051A patent/NZ538051A/en not_active IP Right Cessation
- 2003-07-08 CN CNB038163667A patent/CN100548960C/zh not_active Expired - Lifetime
- 2003-07-08 DE DE60314633T patent/DE60314633T2/de not_active Expired - Lifetime
- 2003-07-08 US US10/520,079 patent/US7943661B2/en active Active
- 2003-07-08 SI SI200330864T patent/SI1525177T1/sl unknown
- 2003-07-08 ES ES03762749T patent/ES2287528T3/es not_active Expired - Lifetime
- 2003-07-08 PT PT03762749T patent/PT1525177E/pt unknown
- 2003-07-08 CA CA2490986A patent/CA2490986C/fr not_active Expired - Fee Related
- 2003-07-08 BR BRPI0312398A patent/BRPI0312398B8/pt not_active IP Right Cessation
- 2003-07-08 MX MXPA05000427A patent/MXPA05000427A/es active IP Right Grant
- 2003-07-08 AU AU2003264698A patent/AU2003264698B2/en not_active Ceased
- 2003-07-08 EP EP03762749A patent/EP1525177B1/fr not_active Expired - Lifetime
- 2003-07-08 DK DK03762749T patent/DK1525177T3/da active
- 2003-07-08 IL IL16569603A patent/IL165696A0/xx unknown
-
2004
- 2004-12-03 NO NO20045301A patent/NO329700B1/no not_active IP Right Cessation
- 2004-12-09 IL IL165696A patent/IL165696A/en active IP Right Grant
-
2005
- 2005-02-07 ZA ZA200501082A patent/ZA200501082B/xx unknown
-
2006
- 2006-07-26 US US11/493,040 patent/US7566737B2/en not_active Expired - Lifetime
-
2007
- 2007-08-03 CY CY20071101040T patent/CY1108085T1/el unknown
-
2011
- 2011-04-11 US US13/083,659 patent/US8058308B2/en not_active Expired - Lifetime
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PL372809A1 (pl) | Podstawione pochodne 1,3-difenyloprop-2-en-1-onu,sposób otrzymywania i zastosowanie podstawionych pochodnych 1,3-difenyloprop-2-enu-1-onu | |
EE200100485A (et) | Uudsed ühendid ja kompositsioonid proteaasi inhibiitoritena | |
WO2004060882A8 (en) | Cb 1/cb 2 receptor ligands and their use in the treatment of pain | |
SE0101387D0 (sv) | Novel compounds | |
BR0113838A (pt) | Derivados de n-fenil-2-pirimidina-amina | |
UY27755A1 (es) | Nuevas composiciones farmacéuticas basadas en anticolinérgicos e inhibidores. | |
NO20053644L (no) | (2S)-2-[(4S)-4-(2,2-difluorvinyl)-2-oksopyrrolidinyl ]butanamid og farmasoytisk preparat | |
NO20062504L (no) | Sammensetninger og doseringsformer for forbedret absorpsjon | |
MY141528A (en) | Anilinopyrazole derivatives useful for the treatment of diabetes | |
SE9802208D0 (sv) | Novel compounds | |
DE602004017326D1 (de) | Tetrahydrocarbazolderivate und deren pharmazeutische verwendung | |
TNSN04034A1 (en) | Combined preparations, containing 1,4-benzothiepine-1,1-dioxide derivatives and other active substances, and the use thereof | |
HRP20050603A2 (en) | Novel anticonvulsant derivative salts | |
SE0300457D0 (sv) | Novel compounds | |
SE9802209D0 (sv) | Novel compounds | |
NO20034985L (no) | Nye 5-tio-SS-D-xylopyranosid-derivater, fremgangsmåte for fremstilling derav, farmasöytiske blandinger inneholdende dem og den terapeutiskeanvendelse derav | |
DE50304524D1 (de) | Arzneimittel enthaltend substituierte 2,5-diaminomethyl-1h-pyrrole | |
EP1452522A3 (en) | Novel compounds and compositions as protease inhibitors | |
MXPA05003633A (es) | 2"-oxo-voruscharina y derivados de la misma. | |
SE9803277D0 (sv) | Novel compounds | |
UY27563A1 (es) | 1,3-diarilprop-2-en-1-onas, composiciones que las contienen y su utilización. | |
DOP2003000766A (es) | Derivados de anilinopirazol utiles en el tratamiento de la diabetes |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RECP | Rectifications of patent specification |